Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steatosis of Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07389122
What this trial is testing

Adherence and Tolerability of Four Very Low-Calorie Ketogenic Diet Approaches in Adults With Obesity or Complicated Overweight

Who this might be right for
Obesity & OverweightMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Type 2 Diabetes+1 more
University of Bologna 110
Testing effectiveness (Phase 2)Study completedNCT04505436
What this trial is testing

Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Hanmi Pharmaceutical Company Limited 215
Early research (Phase 1)Study completedNCT00816465
What this trial is testing

Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Hadassah Medical Organization 20
Testing effectiveness (Phase 2)Ended earlyNCT00068094
What this trial is testing

The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics

Who this might be right for
Fatty LiverHepatic SteatosisDiabetes Mellitus+1 more
National Center for Complementary and Integrative Health (NCCIH) 30
Not applicableStudy completedNCT04180631
What this trial is testing

Quantitative US for Hepatic Steatosis

Who this might be right for
Hepatic Steatosis
Seoul National University Hospital 124
Testing effectiveness (Phase 2)Study completedNCT04321031
What this trial is testing

Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis With Liver Fibrosis
Pfizer 256
Early research (Phase 1)Study completedNCT03681457
What this trial is testing

Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control Subjects

Who this might be right for
Non-alcoholic Fatty Liver Disease
Novartis Pharmaceuticals 42
Not applicableLooking for participantsNCT07685353
What this trial is testing

Influence of Donor and Recipient Genetic Polymorphisms on Graft Steatosis After Liver Transplant

Who this might be right for
Chronic Liver Disease and Cirrhosis
Institute of Liver and Biliary Sciences, India 50
Testing effectiveness (Phase 2)UnknownNCT01617772
What this trial is testing

Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis

Who this might be right for
Non-alcoholic Steatohepatitis
Tehran University of Medical Sciences 440
Not applicableStudy completedNCT04988230
What this trial is testing

Time Restricted Feeding on Nonalcoholic Fatty Liver Disease ( TREATY-FLD )：a 12-month Follow-up Study

Who this might be right for
Nonalcoholic Fatty Liver Disease
Nanfang Hospital, Southern Medical University 88
Not applicableStudy completedNCT02083367
What this trial is testing

Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome

Who this might be right for
Hepatic EncephalopathyCirrhosisNonalcoholic Steatohepatitis+1 more
OSF Healthcare System 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07310407
What this trial is testing

Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Who this might be right for
NAFLD
Ain Shams University 120
Large-scale testing (Phase 3)Study completedNCT05768334
What this trial is testing

Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLD
Helwan University 116
Not applicableActive Not RecruitingNCT06645730
What this trial is testing

Metabolomics Predictors for Metabolic Disease Remission After Metabolic Syndrome Surgery.

Who this might be right for
Metabolic Syndrome
First Affiliated Hospital of Chongqing Medical University 150
Not applicableLooking for participantsNCT04442334
What this trial is testing

The European NAFLD Registry

Who this might be right for
NAFLDNASHNASH - Nonalcoholic Steatohepatitis+9 more
Newcastle University 10,000
Testing effectiveness (Phase 2)Study completedNCT06482112
What this trial is testing

Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNon-alcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease+1 more
Merck Sharp & Dohme LLC 124
Large-scale testing (Phase 3)Looking for participantsNCT07165028
What this trial is testing

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company 4,500
Not applicableStudy completedNCT05092399
What this trial is testing

Effects of VLCD and Bariatric Surgery in Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesNAFLDObesity
University of Nottingham 21
Not applicableLooking for participantsNCT06814600
What this trial is testing

Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients

Who this might be right for
NAFLDInflammatory Bowel DiseasesSteatosis+1 more
Centre Hospitalier Universitaire Saint Pierre 150
Testing effectiveness (Phase 2)Study completedNCT00501592
What this trial is testing

Study of INT-747 in Patients With Diabetes and Presumed NAFLD

Who this might be right for
Diabetes Mellitus, Type IIFatty Liver
Intercept Pharmaceuticals 64
Next Page